TABLE 6.
Univariate analysis of potential determinants of success of hepatocellular cancer ultrasound surveillance in the detection of tumour in curable stages (Barcelona Clinic Liver Cancer [BCLC] stages 0 or A)
| BCLC stage | P | Unadjusted OR (95% CI) | ||
|---|---|---|---|---|
|
| ||||
| B/C/D (n=22) | 0/A (n=113) | |||
| Sex | ||||
| Female | 7 (32) | 22 (19) | 0.255 | 0.52 (0.19–1.42) |
| Male | 15 (68) | 91 (81) | 1.00 | |
| Ethnicity | ||||
| Caucasian | 14 (64) | 68 (60) | 0.761 | 1.00 |
| Other | 8 (36) | 45 (40) | 1.16 (0.45–2.99) | |
| Surveillance interval, months | ||||
| ≤12 | 13 (59) | 84 (74) | 0.146 | 2.01 (0.78–5.18) |
| >12 | 9 (41) | 29 (26) | 1.00 | |
| Cause(s) | ||||
| Hepatitis B | 2 (9) | 29 (26) | 0.402 | 3.05 (0.51–18.34) |
| Hepatitis C | 12 (55) | 51 (45) | 0.90 (0.26–3.12) | |
| Combined | 4 (18) | 14 (12) | 0.74 (0.16–3.47) | |
| Other/unknown | 4 (18) | 19 (17) | 1.00 | |
| Age, years | ||||
| Mean ± SD | 65.8±9.2 | 62.2±10.3 | 0.125 | 0.96 (0.92–1.01) |
| Median (range) | 65 (50–86) | 61 (31–84) | ||
| Year of detection | ||||
| 2000–2005 | 10 (45) | 46 (41) | 0.679 | 1.00 |
| 2006–2010 | 12 (55) | 67 (59) | 1.21 (0.48–3.04) | |
| Child-Pugh class | ||||
| A | 9 (41) | 27 (24) | 0.099 | 2.21 (0.85–5.72) |
| B/C | 13 (59) | 86 (76) | 1.00 | |
| Residence area | ||||
| Beyond metropolitan | 3 (14) | 19 (17) | 0.770 | 1.28 (0.34–4.76) |
| Metropolitan | 19 (86) | 94 (83) | 1.00 | |
Data presented as n (%) unless otherwise indicated